Long term treatment of chronic delta hepatitis with alpha recombinant interferon
Marinucci, G.; Hassan, G.; Di Giacomo, C.; Barlattani, A.; Costa, F.; Rasshofer, R.; Roggendorf, M.
Progress in Clinical and Biological Research 364: 405-410
1991
ISSN/ISBN: 0361-7742 PMID: 2020716 Document Number: 383698
Document emailed within 1 workday
Related Documents
Zielińska, W.; Korczak-Rogoń, A.; Paszkiewicz, J.; Kowalik, M.; Cummins, J.M.; Georgiades, J.A. 1996: Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients Archivum Immunologiae et Therapiae Experimentalis 44(5-6): 359-366Sampliner, R.E. 1991: Long-term effect of alpha-interferon therapy in chronic hepatitis B American Journal of Gastroenterology 86(12): 1838-1839
Carreño, V.; Porres, J.C.; Ruiz-Moreno, M.; Gutiez, J.; Bartolomé, F.J. 1991: A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 79(1): 24-28
Kuloğlu, Z.; Kansu, A.; Erden, E.; Girgin, N. 2010: Efficacy of combined interferon alpha and long-term lamivudine therapy in children with chronic hepatitis B Turkish Journal of Pediatrics 52(5): 457-463
Utili, R.; Sagnelli, E.; Galanti, B.; Aprea, L.; Cesaro, G.; Digilio, L.; Filippini, P.; Felaco, F.M.; Gaeta, G.B.; Marrone, A. 1991: Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study American Journal of Gastroenterology 86(3): 327-330
Perrillo, R.P.; Regenstein, F.G.; Peters, M.G.; DeSchryver-Kecskemeti, K.; Bodicky, C.J.; Campbell, C.R.; Kuhns, M.C. 1988: Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial Annals of Internal Medicine 109(2): 95-100
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Rostaing, L.; Izopet, J.; Baron, E.; Duffaut, M.; Puel, J.; Durand, D. 1995: Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects Transplantation Proceedings 27(1): 948-950
Gaudin, J.L.; Trépo, C. 1993: Therapy of chronic delta hepatitis with alpha- and beta-interferon Progress in Clinical and Biological Research 382: 345-352
Di Bisceglie, A.M.; Negro, F.; Smedile, A.; Bergmann, K.; Hoofnagle, J.H. 1991: Alpha interferon therapy of chronic delta hepatitis: a pilot study Progress in Clinical and Biological Research 364: 393-397
Teuber, G.; Dienes, H.P.; Meyer Zum Büschenfelde, K.H.; Gerken, G. 1996: Long-term follow-up of patients with chronic hepatitis B after interferon treatment Zeitschrift für Gastroenterologie 34(4): 230-236
Tran, A.; Longo, F.; Saint-Paul, M.C.; Doglio, A.; Benzaken, S.; Rampal, P. 2000: Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study Gastroenterologie Clinique et Biologique 24(12): 1234-1235
Bresci, G.; Parisi, G.; Banti, S.; Bertoni, M. 1993: Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up European Journal of Medicine 2(6): 349-352
Musch, E.; Högemann, B.; Gerritzen, A.; Fischer, H.P.; Wiese, M.; Kruis, W.; Malek, M.; Gugler, R.; Schmidt, G.; Huchzermeyer, H.; Gerlach, U.; Dengler, H.J.; Sauerbruch, T. 1998: Phase Ii clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B Hepato-Gastroenterology 45(24): 2282-2294
Casado, L.F.; Picó, M.; Gómez, C.; Ferro, M.T.; Fernández-Rañada, J.M.; Steegmann, J.L. 1997: Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment Medicina Clinica 109(7): 251-255
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Bonaccorso, R.; Teresi, M.; Gebbia, V.; Tambone Reyes, M.; Tinnirello, D.; Di Marco, P.; Citarrella, P.; Mansueto, S. 1989: Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders Journal of ChemoTherapy 1(4 Suppl): 1266-1268
Inoue, O.; Yano, M. 1994: Long-term prognosis after interferon therapy in chronic hepatitis type C Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1828-1831
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191